Back

A new chemical carcinogen and Western diet protocol to reliably induce advanced hepatocellular carcinoma in male and female mice

Mancini, M. C.; Adams, E. R.; Burk, D. H.; Carmouche, R.; Webb, S.; Staszkiewicz, J.; Salbaum, J. M.; Mackintosh, S. G.; Heden, T. D.

2026-03-10 cancer biology
10.64898/2026.03.06.710198 bioRxiv
Show abstract

Background and AimsA combination of chemical carcinogens and Western diet have been used to induce hepatocellular carcinoma (HCC) in mice, but these models show low incidence of HCC in female mice, while mice that do develop HCC show a wide range of HCC stage development. Therefore, a more reliable mouse model that induces advanced stage HCC in both male and female mice is warranted, which will enable reliable preclinical testing of therapeutics for advanced HCC. The purpose of this study was to create a simple, yet tolerable and reliable chemical carcinogen and Western diet induced mouse model of advanced stage HCC for both male and female mice. Approach and ResultsWe report that providing mice with a Western diet at weaning and for their lifetime combined with the sequential administration of low dose diethylnitrosamine (DEN), thioacetamide (TAA), and sucrose water promotes stage 2-3 HCC by 30 weeks of age in 100% of male mice and 96% of female mice (4% had stage 1 HCC), with a low fatality rate. Spatial transcriptomics, proteomics, and western blotting revealed this model alters genes and proteins similar to human HCC. ConclusionsThis study introduces, for the first time, a reliable chemical carcinogen model that induces advanced HCC in both male and female mice. Importantly, the model was tolerable for mice and induced protein and gene signatures comparable to human HCC. This new protocol will be a valuable model for preclinical testing of new therapeutic approaches for advanced HCC.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 4%
27.7%
2
Frontiers in Oncology
95 papers in training set
Top 0.1%
13.6%
3
Cancers
200 papers in training set
Top 0.6%
7.7%
4
Scientific Reports
3102 papers in training set
Top 26%
4.6%
50% of probability mass above
5
BMC Cancer
52 papers in training set
Top 0.5%
3.8%
6
Cancer Medicine
24 papers in training set
Top 0.4%
3.5%
7
Journal of Translational Medicine
46 papers in training set
Top 0.4%
2.2%
8
Archives of Toxicology
14 papers in training set
Top 0.1%
2.0%
9
British Journal of Cancer
42 papers in training set
Top 0.7%
2.0%
10
Archives of Clinical and Biomedical Research
28 papers in training set
Top 0.6%
1.8%
11
International Journal of Cancer
42 papers in training set
Top 0.5%
1.8%
12
PeerJ
261 papers in training set
Top 6%
1.8%
13
BMC Medicine
163 papers in training set
Top 4%
1.4%
14
Metabolomics
11 papers in training set
Top 0.3%
1.2%
15
Frontiers in Pharmacology
100 papers in training set
Top 3%
1.2%
16
Molecules
37 papers in training set
Top 1%
1.0%
17
Frontiers in Molecular Biosciences
100 papers in training set
Top 3%
1.0%
18
Neoplasia
22 papers in training set
Top 0.5%
0.8%
19
Toxicological Sciences
38 papers in training set
Top 0.5%
0.8%
20
Diagnostics
48 papers in training set
Top 2%
0.8%
21
Environmental Research
46 papers in training set
Top 2%
0.7%
22
Biology Methods and Protocols
53 papers in training set
Top 3%
0.7%
23
The Journal of Pharmacology and Experimental Therapeutics
15 papers in training set
Top 0.6%
0.5%
24
Medicine
30 papers in training set
Top 3%
0.5%